Key Players: 色界吧 Manufacturing Companies in India

色界吧 manufacturing companies in India are one of the world鈥檚 largest sources of generic drugs, supplying 50% of global demand for a range of vaccines, 40% of generic demand in the US and 25% of all UK medicine.

It has been predicted that India will be the sixth-largest market for pharmaceuticals globally by 2020. With this in mind, the following is a list of the pharmaceutical manufacturing companies in India that are leading the field.

Sun 色界吧 Industries

As far as pharmaceutical manufacturing companies in India go, Sun Pharma is definitely one of the main ones to watch as, if measured by market capitalisation alone, it is company specialising in generic drugs. The company states that its vision is to be 鈥渞eaching people and touching lives globally as a leading provider of valued medicines鈥.

Sun Pharma manufactures and sells medicines in over 150 countries across six continents. It has over 48 manufacturing facilities across the world and 30 of its brands are among the top 300 pharma brands in India. Sales in the US market account for almost 60% of Sun Pharma鈥檚 annual turnover.

Cipla

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

This global pharmaceutical company has its headquarters in Mumbai. It was founded in 1935 by Dr Khwaja Abdul Hamiedas as the Chemical, Industrial & 色界吧 Laboratories. Cipla sells pharmaceutical ingredients and products and specialises in antiretroviral drugs.

It has 34 manufacturing units in eight locations across India and sells products in over 170 countries. All of its facilities are cGMP compliant and conform to international standards. Cipla’s portfolio includes over 2,000 products across multiple therapeutic categories, including treatments for acute, chronic and rare conditions.

Dr. Reddy鈥檚 Laboratories

This international company is based in Hyderabad, Telengana. It sells a wide range of pharmaceutical products in India and 25 other countries through its three businesses: 色界吧 Services & Active Ingredients, Global Generics and Proprietary Products.

Founded in 1984 by Dr Anji Reddy, the company鈥檚 main focus areas are gastrointestinal, cardiovascular, diabetology, oncology, pain management and anti-infective medications. Dr Reddy鈥檚 has 17 manufacturing facilities in India and six in the US, UK and China. Around 86% of the manufacturer鈥檚 sales are from overseas markets and the US accounts for about 47% of its turnover.

Lupin

Founded in 1968 and based in Mumbai, Lupin is the seventh-largest generic pharmaceutical company in the world by market capitalisation and the 10th-largest generic manufacturer by revenue. The company鈥檚 research and development program covers the entire pharmaceutical production chain. It manufactures and sells a variety of generic and branded drugs, active pharmaceutical ingredients, advanced drug delivery systems and biotechnology products in over 100 countries.

Lupin is the world leader in developing anti-tuberculosis products and specialises in developing other therapy medications such as cardiovascular, anti-asthma, anti-diabetic, anti-infective, gastrointestinal and central nervous system drugs.

Aurobindo

Among the largest vertically integrated pharmaceutical companies in India, Aurobindo manufactures and sells over 300 products in over 150 countries. Like Dr Reddy鈥檚, it is based in Hyderabad, Telangana. The company was founded in 1986 by Mr Ramaprasad Reddy and Mr Nityananda Reddy and was initially a single unit manufacturing semi-synthetic penicillin.

Today, Aurobindo is the market leader in semi-synthetic penicillins and develops products for an array of other areas such as neuroscience, cardiovascular, antiretrovirals, anti-diabetics, gastroenterology and antibiotics. The company features among the top ten companies in India in terms of consolidated revenues and exports to over 125 countries, with over 70% of its revenues coming from overseas.